Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
- Conditions
- Ligament Injury
- Interventions
- Drug: Oral Contraceptive Pill, norethindrn a-e estradiol-iron
- Registration Number
- NCT04899778
- Lead Sponsor
- Cedars-Sinai Medical Center
- Brief Summary
The purpose of this research study is to examine the impact of one type of commonly used birth control pill on blood levels of relaxin and measure changes in knee movement to determine whether there are changes in joint instability (indicating the knee is less stable) that may predispose female athletes to injury. Women not on hormonal birth control will also be enrolled to analyze differences between athletes on and not on birth control and to evaluate typical relaxin levels and knee laxity when birth control pills are not used.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 73
- Female
- 18 years of age or older
- Currently playing basketball, soccer, or volleyball at Loyola Marymount or Pepperdine
- If not currently on COC, regular menstrual cycle occurring every 21-35 days
- Previous ACL injury
- Underlying neuromuscular disease
- Medical contraindication to COC use
- History of pregnancy
- Desire to conceive in the next year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Oral Contraceptive Pill Oral Contraceptive Pill, norethindrn a-e estradiol-iron Oral contraceptive, 1/day, for one year
- Primary Outcome Measures
Name Time Method Injury over the course of 1 year Any injury resulting in time away from practice or competition
- Secondary Outcome Measures
Name Time Method Hip Rotation During a Single-legged Drop baseline, 4 month visit Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.
Knee Rotation During a Single-legged Drop baseline, 4 month visit Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.
Joint Hypermobility baseline, 4 month visit Beighton score will be used to assess overall joint laxity. The Beighton score is on a nine-point scale that is based on 5 joint maneuvers. The maximum score is 9, which indicates increased laxity in the joints. A score of zero indicates inflexible joints.
Serum Relaxin Level baseline, 4 month visit level of relaxin measured in each subject
Anterior Knee Laxity baseline, 4 month visit Anterior Knee laxity will be evaluated using the KT-2000 and measured in millimeters of anterior translation of the tibia relative to the femur
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Cedars Sinai Medical Center
🇺🇸Los Angeles, California, United States
Cedars Sinai Medical Center🇺🇸Los Angeles, California, United StatesNatasha Trentacosta, MDContact310-829-2663natasha.trentacosta@cshs.orgMelodie Metzger, PhDContact3104237765Melodie.Metzger@cshs.org